Renewable energy

Technavio estimates global bipolar disorder therapeutics market to reach over $7.5 billion by 2019

  Segmentation of the bipolar disorder therapeutics market by drug class (mood stabilizers, anticonvulsants, atypical antipsychotics, antidepressant drugs, and anti-anxiety drugs), by mechanism of action (selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, monoamine oxidase inhibitors, benzodiazepines, beta blockers, and others), and by geography (the Americas, APAC, and EMEA). Top vendors include Allergan, AstraZeneca,…

Read More
Renewable energy

Global brain monitoring devices market expected to surpass US $3 billion by 2019, says Technavio

  This market research report by Technavio segments the global brain monitoring devices market by product (EEG, ICP, TCD, MEG, and cerebral oximeter), by application (global epilepsy monitoring devices market and global sleep apnea monitoring devices market), by type (wearable EEG system and conventional EEG system), and by geography (APAC, EMEA, and the Americas). Leading…

Read More
Renewable energy

The European epilepsy drugs market expected to reach around US $1,200 million by 2019, says Technavio

  Epilepsy drugs: Key market research findings Arrival of new-generation anti-epileptic drugs Increased adoption of reformulation strategies by vendors Technavio has added a new market research report on the European epilepsy drugs market, to its epilepsy portfolio. The epilepsy drugs market in Europe is expected to grow at a CAGR of around 3% between 2015…

Read More